Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Sandler

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Urology|March 27, 2007
Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10Javier F Torres-Roca, Michelle DeSilvio, Linda B Mora, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 20, 2010
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995Howard D Thames, Deborah Kuban, Larry B Levy, et al.
The Journal of Sexual Medicine|January 18, 2011
Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215Deborah Watkins Bruner, Jennifer L James, Charlene J Bryan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610Min Zhang, Alex Ho, Elizabeth H Hammond, et al.
Seminars in Radiation Oncology|March 28, 2002
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406Jeff M Michalski, Kathryn Winter, James A Purdy, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 13, 2024
Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment ConsultationsAurash Naser-Tavakolian, Rebecca Gale, Michael Luu, et al.
The Oncologist|June 4, 2013
Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survivalTim Lautenschlaeger, Asha George, Alexander C Klimowicz, et al.
European Urology Oncology|December 18, 2025
Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysisPraful Ravi, Lucia Kwak, Wanling Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2013
Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancerSkyler B Johnson, Daniel A Hamstra, William C Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2014
Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancerMatthew H Stenmark, Anna S C Conlon, Skyler Johnson, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Urology|March 27, 2007
Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10Javier F Torres-Roca, Michelle DeSilvio, Linda B Mora, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 20, 2010
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995Howard D Thames, Deborah Kuban, Larry B Levy, et al.
The Journal of Sexual Medicine|January 18, 2011
Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215Deborah Watkins Bruner, Jennifer L James, Charlene J Bryan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610Min Zhang, Alex Ho, Elizabeth H Hammond, et al.
Seminars in Radiation Oncology|March 28, 2002
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406Jeff M Michalski, Kathryn Winter, James A Purdy, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 13, 2024
Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment ConsultationsAurash Naser-Tavakolian, Rebecca Gale, Michael Luu, et al.
The Oncologist|June 4, 2013
Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survivalTim Lautenschlaeger, Asha George, Alexander C Klimowicz, et al.
European Urology Oncology|December 18, 2025
Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysisPraful Ravi, Lucia Kwak, Wanling Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2013
Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancerSkyler B Johnson, Daniel A Hamstra, William C Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2014
Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancerMatthew H Stenmark, Anna S C Conlon, Skyler Johnson, et al.
Pageof 12